Table:
begin	end	state
1	29	cytoplasmic
30	49	transmembrane
50	68	non-cytoplasmic
69	90	transmembrane
91	96	cytoplasmic
97	116	transmembrane
117	121	non-cytoplasmic
122	139	transmembrane
140	161	cytoplasmic
162	183	transmembrane
184	213	non-cytoplasmic
214	234	transmembrane
235	267	cytoplasmic
268	291	transmembrane
292	302	non-cytoplasmic
303	324	transmembrane
325	330	cytoplasmic
331	350	transmembrane
351	355	non-cytoplasmic
356	378	transmembrane
379	389	cytoplasmic
390	410	transmembrane
411	417	non-cytoplasmic
418	440	transmembrane
441	444	cytoplasmic

Input:
>BWI76_RS23685 FitnessBrowser__Koxy:BWI76_RS23685
MSTLITDKVDKAAVHNEKLDTSAYLPHTPWLQFLLVCCLFALWGMAGNLNDILIAQFKKG
FDLTDTQTALVQSIFFLGYFFVALPAAALIKRYSYKAAIIIGLCLYALGCFLFVPAAQIM
TYGAFLACLGVIACGLSFLETSANTYSSLLGPIQSSTQRINFSQIFNSLGVISGVLIGQV
MVFGENDPSHEQLLAMPAAAADAARHQMVGQVVGPYLIIGSVLVVLALVFVFIKFPSCKG
TPSQQQQIPTESMGSTLKRLFAIPRFRLGILSQFLYVGAQVGVWSFTIRFVQLVQQGTSE
HSATYWLLASLVIYAVGKTVATWLMNRLNPALLLGTFALAATVLLLIAVFSSSMLAVYAL
ILVSFCMAPCWPTNFGLVIKGMGKDTQTAGSIVVMSIIGGAVIPLVMGIISDMNGGNMQI
AFIAPLLCFVYVAFYGFWCVRKGV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server